COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Phase I Clinical Study of Recombinant Novel Coronavirus Vaccine

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT04445194
Recruitment Status : Recruiting
First Posted : June 24, 2020
Last Update Posted : July 2, 2020
The Second Affiliated Hospital of Chongqing Medical University
Beijing Chao Yang Hospital
Information provided by (Responsible Party):
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : July 21, 2021
Estimated Study Completion Date : September 20, 2021